Copyright Reports & Markets. All rights reserved.

Global Tuberculosis Vaccines Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Tuberculosis Vaccines

      • 1.1 Definition of Tuberculosis Vaccines
      • 1.2 Tuberculosis Vaccines Segment by Type
        • 1.2.1 Global Tuberculosis Vaccines Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Immunotherapeutic Vaccines
        • 1.2.3 Booster Vaccines
        • 1.2.4 Others
      • 1.3 Tuberculosis Vaccines Segment by Applications
        • 1.3.1 Global Tuberculosis Vaccines Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Others
      • 1.4 Global Tuberculosis Vaccines Overall Market
        • 1.4.1 Global Tuberculosis Vaccines Revenue (2014-2025)
        • 1.4.2 Global Tuberculosis Vaccines Production (2014-2025)
        • 1.4.3 North America Tuberculosis Vaccines Status and Prospect (2014-2025)
        • 1.4.4 Europe Tuberculosis Vaccines Status and Prospect (2014-2025)
        • 1.4.5 China Tuberculosis Vaccines Status and Prospect (2014-2025)
        • 1.4.6 Japan Tuberculosis Vaccines Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Tuberculosis Vaccines Status and Prospect (2014-2025)
        • 1.4.8 India Tuberculosis Vaccines Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccines
      • 2.3 Manufacturing Process Analysis of Tuberculosis Vaccines
      • 2.4 Industry Chain Structure of Tuberculosis Vaccines

      3 Development and Manufacturing Plants Analysis of Tuberculosis Vaccines

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Tuberculosis Vaccines Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Tuberculosis Vaccines
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Tuberculosis Vaccines Production and Capacity Analysis
      • 4.2 Tuberculosis Vaccines Revenue Analysis
      • 4.3 Tuberculosis Vaccines Price Analysis
      • 4.4 Market Concentration Degree

      5 Tuberculosis Vaccines Regional Market Analysis

      • 5.1 Tuberculosis Vaccines Production by Regions
        • 5.1.1 Global Tuberculosis Vaccines Production by Regions
        • 5.1.2 Global Tuberculosis Vaccines Revenue by Regions
      • 5.2 Tuberculosis Vaccines Consumption by Regions
      • 5.3 North America Tuberculosis Vaccines Market Analysis
        • 5.3.1 North America Tuberculosis Vaccines Production
        • 5.3.2 North America Tuberculosis Vaccines Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Tuberculosis Vaccines Import and Export
      • 5.4 Europe Tuberculosis Vaccines Market Analysis
        • 5.4.1 Europe Tuberculosis Vaccines Production
        • 5.4.2 Europe Tuberculosis Vaccines Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Tuberculosis Vaccines Import and Export
      • 5.5 China Tuberculosis Vaccines Market Analysis
        • 5.5.1 China Tuberculosis Vaccines Production
        • 5.5.2 China Tuberculosis Vaccines Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Tuberculosis Vaccines Import and Export
      • 5.6 Japan Tuberculosis Vaccines Market Analysis
        • 5.6.1 Japan Tuberculosis Vaccines Production
        • 5.6.2 Japan Tuberculosis Vaccines Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Tuberculosis Vaccines Import and Export
      • 5.7 Southeast Asia Tuberculosis Vaccines Market Analysis
        • 5.7.1 Southeast Asia Tuberculosis Vaccines Production
        • 5.7.2 Southeast Asia Tuberculosis Vaccines Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Tuberculosis Vaccines Import and Export
      • 5.8 India Tuberculosis Vaccines Market Analysis
        • 5.8.1 India Tuberculosis Vaccines Production
        • 5.8.2 India Tuberculosis Vaccines Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Tuberculosis Vaccines Import and Export

      6 Tuberculosis Vaccines Segment Market Analysis (by Type)

      • 6.1 Global Tuberculosis Vaccines Production by Type
      • 6.2 Global Tuberculosis Vaccines Revenue by Type
      • 6.3 Tuberculosis Vaccines Price by Type

      7 Tuberculosis Vaccines Segment Market Analysis (by Application)

      • 7.1 Global Tuberculosis Vaccines Consumption by Application
      • 7.2 Global Tuberculosis Vaccines Consumption Market Share by Application (2014-2019)

      8 Tuberculosis Vaccines Major Manufacturers Analysis

      • 8.1 Sanofi
        • 8.1.1 Sanofi Tuberculosis Vaccines Production Sites and Area Served
        • 8.1.2 Sanofi Product Introduction, Application and Specification
        • 8.1.3 Sanofi Tuberculosis Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Merck
        • 8.2.1 Merck Tuberculosis Vaccines Production Sites and Area Served
        • 8.2.2 Merck Product Introduction, Application and Specification
        • 8.2.3 Merck Tuberculosis Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Serum Institute of India
        • 8.3.1 Serum Institute of India Tuberculosis Vaccines Production Sites and Area Served
        • 8.3.2 Serum Institute of India Product Introduction, Application and Specification
        • 8.3.3 Serum Institute of India Tuberculosis Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 GlaxoSmithKline
        • 8.4.1 GlaxoSmithKline Tuberculosis Vaccines Production Sites and Area Served
        • 8.4.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.4.3 GlaxoSmithKline Tuberculosis Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Japan BCG Lab
        • 8.5.1 Japan BCG Lab Tuberculosis Vaccines Production Sites and Area Served
        • 8.5.2 Japan BCG Lab Product Introduction, Application and Specification
        • 8.5.3 Japan BCG Lab Tuberculosis Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 IDT Biologics
        • 8.6.1 IDT Biologics Tuberculosis Vaccines Production Sites and Area Served
        • 8.6.2 IDT Biologics Product Introduction, Application and Specification
        • 8.6.3 IDT Biologics Tuberculosis Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 GreenSignal Bio Pharma
        • 8.7.1 GreenSignal Bio Pharma Tuberculosis Vaccines Production Sites and Area Served
        • 8.7.2 GreenSignal Bio Pharma Product Introduction, Application and Specification
        • 8.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Taj Pharmaceuticals
        • 8.8.1 Taj Pharmaceuticals Tuberculosis Vaccines Production Sites and Area Served
        • 8.8.2 Taj Pharmaceuticals Product Introduction, Application and Specification
        • 8.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Bavarian Nordic
        • 8.9.1 Bavarian Nordic Tuberculosis Vaccines Production Sites and Area Served
        • 8.9.2 Bavarian Nordic Product Introduction, Application and Specification
        • 8.9.3 Bavarian Nordic Tuberculosis Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 China National Biotec Group
        • 8.10.1 China National Biotec Group Tuberculosis Vaccines Production Sites and Area Served
        • 8.10.2 China National Biotec Group Product Introduction, Application and Specification
        • 8.10.3 China National Biotec Group Tuberculosis Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Tuberculosis Vaccines Market

      • 9.1 Global Tuberculosis Vaccines Market Trend Analysis
        • 9.1.1 Global Tuberculosis Vaccines Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Tuberculosis Vaccines Regional Market Trend
        • 9.2.1 North America Tuberculosis Vaccines Forecast 2019-2025
        • 9.2.2 Europe Tuberculosis Vaccines Forecast 2019-2025
        • 9.2.3 China Tuberculosis Vaccines Forecast 2019-2025
        • 9.2.4 Japan Tuberculosis Vaccines Forecast 2019-2025
        • 9.2.5 Southeast Asia Tuberculosis Vaccines Forecast 2019-2025
        • 9.2.6 India Tuberculosis Vaccines Forecast 2019-2025
      • 9.3 Tuberculosis Vaccines Market Trend (Product Type)
      • 9.4 Tuberculosis Vaccines Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Tuberculosis Vaccines Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.

        The global Tuberculosis Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Tuberculosis Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tuberculosis Vaccines market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Tuberculosis Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Tuberculosis Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Sanofi
        Merck
        Serum Institute of India
        GlaxoSmithKline
        Japan BCG Lab
        IDT Biologics
        GreenSignal Bio Pharma
        Taj Pharmaceuticals
        Bavarian Nordic
        China National Biotec Group

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Immunotherapeutic Vaccines
        Booster Vaccines
        Others

        Segment by Application
        Hospitals
        Clinics
        Others

        Buy now